198 related articles for article (PubMed ID: 27415031)
1. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt LJ; Stanworth SJ; Doree C; Hopewell S; Trivella M; Murphy MF
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010983. PubMed ID: 26576687
[TBL] [Abstract][Full Text] [Related]
3. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Crighton GL; Estcourt LJ; Wood EM; Trivella M; Doree C; Stanworth S
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010981. PubMed ID: 26422767
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
5. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
6. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
7. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
8. Platelet transfusion goals in oncology patients.
Fasano RM; Josephson CD
Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
[TBL] [Abstract][Full Text] [Related]
9. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
10. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
Benjamin RJ; Anderson KC
Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
[TBL] [Abstract][Full Text] [Related]
11. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.
Schiffer CA
Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734
[No Abstract] [Full Text] [Related]
12. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
Gubanova MN; Ayupova RF; Zhiburt EB
Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
[TBL] [Abstract][Full Text] [Related]
13. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
15. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
Karakatsanis SJ; Papadatos SS; Syrigos KN
Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
[TBL] [Abstract][Full Text] [Related]
16. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.
Tay J; Allan D; Beattie S; Bredeson C; Fergusson D; Maze D; Sabloff M; Thavorn K; Tinmouth A
BMJ Open; 2016 Oct; 6(10):e013483. PubMed ID: 27798034
[TBL] [Abstract][Full Text] [Related]
18. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
[TBL] [Abstract][Full Text] [Related]
19. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
Vinholt PJ; Alnor A; Nybo M; Hvas AM
Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
[TBL] [Abstract][Full Text] [Related]
20. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
